日本皮膚科学会 基礎医学研究費（資生堂寄付）

2018.3  

第17回 ガルデルマ賞

2016.12   ガルデルマ株式会社/日本研究皮膚科学会  

優秀演題賞

2016.8   日本美容皮膚科学会総会  

ポスター賞

2016.6   日本皮膚科学会総会  

アブストラクト賞

2015.5   日本皮膚科学会総会  

ポスター賞

2010.4   日本皮膚科学会総会  

The therapeutic AHR-modulating agent Tapinarof regulates semaphorin 3A expression in human keratinocytes via NRF2. Reviewed International journal

Gaku Tsuji, Ayako Yumine, Kazuhiko Yamamura, Masaki Takemura, Makiko Kido-Nakahara, Takamichi Ito, Takeshi Nakahara

The Journal of Investigative Dermatology   2023.10

Regulatory Mechanism of the IL-33-IL-37 Axis via Aryl Hydrocarbon Receptor in Atopic Dermatitis and Psoriasis. [Review] Reviewed International journal

Gaku Tsuji, Kazuhiko Yamamura, Koji Kawamura, Makiko Kido-Nakahara, Takamichi Ito, Takeshi Nakahara

International Journal of Molecular Sciences   24 ( 19 )   2023.9

Systemic therapy for Asian patients with advanced BRAF V600-mutant melanoma in a real-world setting: A multi-center retrospective study in Japan (B-CHECK-RWD study). Reviewed International journal

Kenjiro Namikawa, Takamichi Ito, Shusuke Yoshikawa, Koji Yoshino, Yukiko Kiniwa, Shuichi Ohe, Taiki Isei, Tatsuya Takenouchi, Hiroshi Kato, Satoru Mizuhashi, Satoshi Fukushima, Yosuke Yamamoto, Takashi Inozume, Yasuhiro Fujisawa, Osamu Yamasaki, Yasuhiro Nakamura, Jun Asai, Takeo Maekawa, Takeru Funakoshi, Shigeto Matsushita, Eiji Nakano, Kohei Oashi, Junji Kato, Hisashi Uhara, Takuya Miyagawa, Hiroshi Uchi, Naohito Hatta, Keita Tsutsui, Taku Maeda, Taisuke Matsuya, Hiroto Yanagisawa, Ikko Muto, Mao Okumura, Dai Ogata, Naoya Yamazaki

Cancer Medicine   2023.8

KS-EMPD-1: a novel cell line of primary extramammary Paget's disease. Reviewed

Takamichi Ito, Yuka Tanaka, Toshio Ichiki, Yumiko Kaku-Ito, Takeshi Nakahara

Human Cell   2023.7

Adverse events associated with postoperative outcomes of adjuvant anti-PD-1 antibody therapy in both acral and non-acral cutaneous melanomas: A multicenter, observational, post hoc analysis study. Reviewed International journal

Yusuke Muto, Yumi Kambayashi, Hiroshi Kato, Satoshi Fukushima, Takamichi Ito, Takeo Maekawa, Yasuhiro Fujisawa, Koji Yoshino, Hiroshi Uchi, Shigeto Matsushita, Yuki Yamamoto, Ryo Amagai, Kentaro Ohuchi, Akira Hashimoto, Yoshihide Asano, Taku Fujimura

The Journal of Dermatology   2023.7

Histological and immunohistochemical prognostic factors of primary angiosarcoma. Reviewed International journal

Toshio Ichiki, Yuichi Yamada, Takamichi Ito, Takeshi Nakahara, Yasuharu Nakashima, Masafumi Nakamura, Tomoharu Yoshizumi, Akira Shiose, Koichi Akashi, Yoshinao Oda

Virchow Arch   483 ( 1 )   59 - 69   2023.6

Postoperative adjuvant therapy for 120 melanoma patients, including acral and mucosal subtypes: A multicenter, observational study of two-year follow-up results. Reviewed International journal

Yusuke Muto, Yumi Kambayashi, Hiroshi Kato, Satoshi Fukushima, Takamichi Ito, Takeo Maekawa, Ishizuki Shoichiro, Hiroshi Uchi, Shigeto Matsushita, Yuki Yamamoto, Koji Yoshino, Yasuhiro Fujisawa, Ryo Amagai, Kentaro Ohuchi, Akira Hashimoto, Yoshihide Asano, Taku Fujimura

The British Journal of Dermatology   2023.5

Novel Therapeutic Targets for the Treatment of Atopic Dermatitis. Reviewed International journal

Gaku Tsuji, Kazuhiko Yamamura, Koji Kawamura, Makiko Kido-Nakahara, Takamichi Ito, Takeshi Nakahara

Biomedicines   11 ( 5 )   2023.4

Combined use of nivolumab and ipilimumab among Japanese melanoma patients: Multi-center, retrospective study of 111 cases. Reviewed International journal

Yasuhiro Fujisawa, Kenjiro Namikawa, Koji Yoshino, Yukiko Kiniwa, Takamichi Ito, Hiroshi Kato, Shigeto Matsushita, Toshihiko Hoashi, Yasuhiro Nakamura, Shusuke Yoshikawa, Takuya Miyagawa, Jun Asai, Taisuke Matsuya, Satoshi Fukushima, Jyunji Kato, Tatsuya Takenouchi, Hiroshi Uchi, Mamiko Masuzawa, Teruki Yanagi, Takeo Maekawa

The British Journal of Dermatology   2023.4

PDE4 inhibition by difamilast regulates filaggrin and loricrin expression via keratinocyte proline-rich protein in human keratinocytes. Reviewed International journal

Gaku Tsuji, Akiko Hashimoto-Hachiya, Ayako Yumine, Masaki Takemura, Makiko Kido-Nakahara, Takamichi Ito, Kazuhiko Yamamura, Takeshi Nakahara

Journal of Dermatological Science   110 ( 2 )   61 - 68   2023.4

Treatment for taxane-resistant cutaneous angiosarcoma: A multicenter study of 50 Japanese cases. Reviewed International journal

Taku Fujimura, Takeo Maekawa, Hiroshi Kato, Takamichi Ito, Shigeto Matsushita, Koji Yoshino, Yasuhiro Fujisawa, Shoichiro Ishizuki, Kojiro Segawa, Jun Yamamoto, Akira Hashimoto, Yumi Kambayashi, Yoshihide Asano

The Journal of Dermatology   2023.3

Analyzing the relationship between the efficacy of first-line immune checkpoint inhibitors and cumulative sun damage in Japanese patients with advanced BRAF wild-type nonacral cutaneous melanoma: A retrospective real-world, multicenter study. Reviewed International journal

Takashi Inozume, Kenjiro Namikawa, Hiroshi Kato, Shusuke Yoshikawa, Yukiko Kiniwa, Koji Yoshino, Satoru Mizuhashi, Takamichi Ito, Tatsuya Takenouchi, Shigeto Matsushita, Yasuhiro Fujisawa, Takamitsu Matsuzawa, Satoru Sugihara, Jun Asai, Hiroshi Kitagawa, Takeo Maekawa, Taiki Isei, Masahito Yasuda, Naoya Yamazaki, Hisashi Uhara, Yasuhiro Nakamura

Journal of Dermatological Science   110 ( 1 )   19 - 26   2023.3

Nail Apparatus Melanoma: Current Management and Future Perspectives. [Review] Invited Reviewed International journal

Takamichi Ito, Hiroki Hashimoto, Yumiko Kaku-Ito, Yuka Tanaka, Takeshi Nakahara

Journal of Clinical Medicine   12 ( 6 )   2023.3

Human epidermal growth factor receptor 3 serves as a novel therapeutic target for acral melanoma. Reviewed International journal

Yuka Tanaka, Takamichi Ito, Yumiko Kaku-Ito, Keiko Tanegashima, Gaku Tsuji, Makiko Kido-Nakahara, Yoshinao Oda, Takeshi Nakahara

Cell Death Discovery   9 ( 1 )   54 - 54   2023.2

Cutaneous angiosarcoma treated with taxane-based chemoradiotherapy: A multicenter study of 90 Japanese cases. Reviewed International journal

Taku Fujimura, Sadanori Furudate, Takeo Maekawa, Hiroshi Kato, Takamichi Ito, Shigeto Matsushita, Koji Yoshino, Akira Hashimoto, Yusuke Muto, Kentaro Ohuchi, Ryo Amagai, Yumi Kambayashi, Yasuhiro Fujisawa

Skin Health and Disease   3 ( 1 )   e180   2023.2

TRPM1 promotes tumor progression in acral melanoma by activating the Ca2+/CaMKIIδ/AKT pathway. Reviewed International journal

43   45 - 57   2023.1

Nectin cell adhesion molecule 4 regulates angiogenesis through Src signaling and serves as a novel therapeutic target in angiosarcoma Reviewed International journal

Yuka Tanaka, Maho Murata, Keiko Tanegashima, Yoshinao Oda, Takamichi Ito

Scientific Reports   12 ( 1 )   2022.12

Concordance in judgment of clinical borders of basal cell carcinomas in Japanese patients: A preliminary study of JCOG2005 (J-BASE-MARGIN) Reviewed

Anna Kamimura, Yasuhiro Nakamura, Tatsuya Takenouchi, Shigeto Matsushita, Toshikazu Omodaka, Kentaro Yamamura, Hiroshi Uchi, Shusuke Yoshikawa, Hiroto Yanagisawa, Takamichi Ito, Yoshio Kiyohara, Yoshio Nakamura, Megumi Aoki, Shoichiro Ishizuki, Kohei Oashi, Takuya Miyagawa, Taku Maeda, Dai Ogata, Naohito Hatta, Shuichi Ohe, Taiki Isei, Akira Takahashi, Yoshiyasu Umeda, Buntaro Yamaguchi, Masashi Ishikawa, Kohei Horimoto, Yasuhiro Fujsawa, Jiro Uehara, Yoshitsugu Shibayama, Yukiko Kiniwa, Yu Kawahara, Taisuke Matsuya, Hisashi Uhara, Junji Kato, Yoshiyuki Nakamura, Takuo Murakami, Kenjiro Namikawa, Koji Yoshino, Takeru Funakoshi, Sumiko Takatsuka, Yu Matsui, Jin Sasaki, Hiroshi Koga, Kenji Yokota, Takaya Komori, Satoshi Fukushima, Naoya Yamazaki

Journal of Dermatology   49 ( 9 )   837 - 844   2022.9

Adjuvant Anti-PD-1 Antibody Therapy for Advanced Melanoma: A Multicentre Study of 78 Japanese Cases. Reviewed International journal

Yusuke Muto, Yumi Kambayashi, Hiroshi Kato, Satoshi Fukushima, Takamichi Ito, Takeo Maekawa, Yasuhiro Fujisawa, Koji Yoshino, Hiroshi Uchi, Shigeto Matsushita, Yuki Yamamoto, Ryo Amagai, Kentaro Ohuchi, Akira Hashimoto, Taku Fujimura

Acta Dermato-Venereologica   102   adv00756   2022.8

Current Management and Treatment of Extramammary Paget's Disease. [review] Invited Reviewed International journal

Hiroki Hashimoto, Takamichi Ito

Current Treatment Options in Oncology   23 ( 6 )   818 - 830   2022.6

Nectin-4: a Novel Therapeutic Target for Skin Cancers. [review] Invited Reviewed International journal

Hiroki Hashimoto, Yuka Tanaka, Maho Murata, Takamichi Ito

Current Treatment Options in Oncology   23 ( 4 )   578 - 593   2022.4

NECTIN4 expression in sebaceous and sweat gland carcinoma Reviewed

Takamichi Ito, Hiroki Hashimoto, Yuka Tanaka, Keiko Tanegashima, Maho Murata, Yoshinao Oda, Yumiko Kaku-Ito

European Journal of Dermatology   32 ( 2 )   181 - 186   2022.3

TROP2 Expression in Sebaceous and Sweat Gland Carcinoma. Reviewed International journal

Ito T, Hashimoto H, Tanaka Y, Tanegashima K, Murata M, Ichiki T, Iwasaki T, Oda Y, Kaku-Ito Y.

J Clin Med. 2022 Jan 25;11(3):607.   2022.1

Trop2 Expression in Extramammary Paget's Disease and Normal Skin. Reviewed International journal

Ito T, Tanegashima K, Tanaka Y, Hashimoto H, Murata M, Oda Y, Kaku-Ito Y.

Int J Mol Sci. 2021 Jul 19;22(14):7706.   2021.6

CDK4: A Novel Therapeutic Target for Extramammary Paget's Disease. Reviewed International journal

Hashimoto H, Kaku-Ito Y, Oda Y, Ito T.

Front Oncol. 2021 Jul 29;11:710378.   11   710378 - 710378   2021.6

Outcome of combination therapy using BRAF and MEK inhibitors among Asian patients with advanced melanoma: An analysis of 112 cases. Reviewed International journal

Fujisawa Y, Ito T, Kato H, Irie H, Kaji T, Maekawa T, Asai J, Yamamoto Y, Fujimura T, Nakai Y, Yasuda M, Matsuyama K, Muto I, Matsushita S, Uchi H, Nakamura Y, Uehara J, Yoshino K.

Eur J Cancer 145: 210-220, 2021   2021.4

Mucosal Invasion, but Not Incomplete Excision, Has Negative Impact on Long-Term Survival in Patients With Extramammary Paget’s Disease Reviewed International journal

11   2021.4

Nectin cell adhesion molecule 4 (Nectin4) expression in cutaneous squamous cell carcinoma: A new therapeutic target? Reviewed International journal

Yuka Tanaka, Maho Murata, Yoshinao Oda, Masutaka Furue, Takamichi Ito

Biomedicines   9 ( 4 )   2021.4

The outcome of chemotherapy for metastatic extramammary Paget’s disease. Reviewed International journal

2021.4

The clinical and histopathological features of cutaneous immune-related adverse events and their outcomes. Reviewed International journal

Hashimoto H, Ito T, Ichiki T, Yamada Y, Oda Y, Furue M.

J Clin Med 10: 728., 2021   2021.4

Case series of BRAF mutated advanced melanoma treated with encorafenib plus binimetinib combined therapy. Reviewed International journal

Fujimura T, Yoshino K, Kato H, Fujisawa Y, Nakamura Y, Yamamoto Y, Kurimoto K, Ito T, Matsushita S, Maekawa T, Ohuchi K, Amagai R, Muto Y, Kambayashi Y, Hashimoto A, Aiba S.

J Dermatol 48: 397-400, 2021.   2021.4

Preoperative screening CT/PET(-CT) scans for acral melanoma: Is it necessary? Reviewed International journal

Ide T, Ito T, Wada-Ohno M, Furue M.

J Clin Med 10: 811., 2021   2021.4

NECTIN4: A novel therapeutic target for melanoma. Reviewed International journal

Tanaka Y, Murata M, Shen CH, Furue M, Ito T*.

Int J Mol Sci 22: 976., 2021.   2021.4

Eosinophilic infiltration discriminates lichen-planus-like eruption caused by an immune checkpoint inhibitor from ordinary lichen planus. Reviewed International journal

Hashimoto H, Ito T, Yamada Y, Oda Y, Furue M.

J Dermatol 48: e102-103, 2021.   2021.4

Continuous monitoring of neutrophils to lymphocytes ratio for estimating the onset, severity, and subsequent prognosis of immune related adverse events. Reviewed International journal

Matsukane R, Watanabe H, Minami H, Hata K, Suetsugu K, Tsuji T, Masuda S, Okamoto I, Nakagawa T, Ito T, Eto M, Mori M, Nakanishi Y, Egashira N.

Sci Rep 11: 1324., 2021   2021.4

BRAF Heterogeneity in Melanoma. [review] Reviewed International journal

Takamichi Ito, Yuka Tanaka, Maho Murata, Yumiko Kaku-Ito, Kazuhisa Furue, Masutaka Furue

Current treatment options in oncology   22 ( 3 )   20 - 20   2021.2

Baicalein inhibits benzo[a]pyrene-induced toxic response by downregulating Src phosphorylation and by upregulating NRF2-HMOX1 system. Reviewed International journal

Tanaka Y, Ito T, Tsuji G, Furue M.

Antioxidants (Basel) 9: 507., 2020   2020.4

The CCL20 and CCR6 axis in psoriasis.[Review] Reviewed

Furue K, Ito T, Tsuji G, Nakahara T, Furue M.

2020.4

Pathogenic implication of epidermal scratch injury in psoriasis and atopic dermatitis.[Review] Reviewed

Furue K, Ulzii D, Tanaka Y, Ito T, Tsuji G, Kido-Nakahara M, Nakahara T, Furue M.

2020.4

NECTIN4 Expression in Extramammary Paget's Disease: Implication of a New Therapeutic Target. Reviewed International journal

Murata M, Ito T*, Tanaka Y, Kaku-Ito Y, Furue M.

Int J Mol Sci 21:5891., 2020   2020.4

Scratch wound-induced CXCL8 upregulation is EGFR-dependent in keratinocytes. Reviewed International journal

Furue K, Ito T, Tsuji G, Nakahara T, Furue M.

J Dermatol Sci 99: 209-212, 2020   2020.4

Narrow margin excision for acral melanoma: Is it acceptable? Reviewed International journal

Ito T*, Kaku-Ito Y, Wada-Ohno M, Furue M.

J Clin Med 9: 2266., 2020   2020.4

Immunohistochemical BRAF V600E expression and intratumor BRAF V600E heterogeneity in acral melanoma: Implication in melanoma-specific survival. Reviewed International journal

Ito T*, Kaku-Ito Y, Murata M, Furue K, Shen CH, Oda Y, Furue M.

J Clin Med.   9 ( 3 )   2020.3

Aryl hydrocarbon receptor activation downregulates IL-33 expression in keratinocytes via ovo-like 1. Reviewed International journal

Tsuji G, Hashimoto-Hachiya A, Yen V, Miake S, Takemura M, Mitamura Y, Ito T, Murata M, Furue M, Nakahara T.

J Clin Med.   2020.3

Japanese Dermatological Association Guidelines: Outlines of guidelines for cutaneous melanoma 2019. International journal

Yasuhiro Nakamura, Jun Asai, Hiroshi Igaki, Takashi Inozume, Kenjiro Namikawa, Ayato Hayashi, Satoshi Fukushima, Taku Fujimura, Takamichi Ito, Keisuke Imafuku, Ryota Tanaka, Yukiko Teramoto, Akane Minagawa, Takuya Miyagawa, Azusa Miyashita, Makoto Wada, Hiroshi Koga, Makoto Sugaya

The Journal of dermatology   47 ( 2 )   89 - 103   2020.2

The EGFR-ERK/JNK-CCL20 Pathway in Scratched Keratinocytes May Underpin Koebnerization in Psoriasis Patients. Reviewed International journal

2020.2

OVOL2-mediated ZEB1 downregulation may prevent promotion of actinic keratosis to squamous cell carcinoma. Reviewed International journal

Murata M, Ito T*, Yamamura K, Hashimoto-Hachiya A, Furue K, Furue M.

J Clin Med   9 ( 3 )   2020.2

Japanese Dermatological Association Guidelines: Outlines of guidelines for cutaneous melanoma 2019. Reviewed International journal

Nakamura Y, Asai J, Igaki H, Inozume T, Namikawa K, Hayashi A, Fukushima S, Fujimura T, Ito T, Imafuku K, Tanaka R, Teramoto Y, Minagawa A, Miyagawa T, Miyashita A, Wada M, Koga H, Sugaya M.

J Dermatol   2020.1

Intra- and Inter-Tumor BRAF Heterogeneity in Acral Melanoma: An Immunohistochemical Analysis. Reviewed International journal

Ito T*, Kaku-Ito Y, Murata M, Ichiki T, Kuma Y, Tanaka Y, Ide T, Ohno F, Wada-Ohno M, Yamada Y, Oda Y, Furue M.

Int J Mol Sci.   20 ( 24 )   2019.12

The IL-13-OVOL1-FLG axis in atopic dermatitis.[Review] Reviewed

Furue K, Ito T, Tsuji G, Ulzii D, Vu YH, Kido-Nakahara M, Nakahara T, Furue M.

2019.11

Indirubin-pregnane X receptor-JNK axis accelerates skin wound healing. Reviewed International journal

Tanaka Y, Uchi H, Ito T, Furue M.

Sci Rep.   2019.10

Does mechanical scratching cause the recruitment of T-helper 17 cells in atopic dermatitis?[Review] Reviewed

Furue K, Ito T, Tsuji G, Esaki H, Kido-Nakahara M, Nakahara T, Furue M.

2019.10

Cyto/chemokine profile of in vitro scratched keratinocyte model: Implications of significant upregulation of CCL20, CXCL8 and IL36G in Koebner phenomenon. Reviewed International journal

Furue K, Ito T, Tanaka Y, Yumine A, Hashimoto-Hachiya A, Takemura M, Murata M, Yamamura K, Tsuji G, Furue M.

J Dermatol Sci   94 ( 1 )   244 - 251   2019.9

Adjuvant Therapy for Melanoma.[Review] Invited Reviewed

Wada-Ohno M, Ito T, Furue M.

2019.9

Implications of tryptophan photoproduct FICZ in oxidative stress and terminal differentiation of keratinocytes.[Review] Reviewed

Furue M, Uchi H, Mitoma C, Hashimoto-Hachiya A, Tanaka Y, Ito T, Tsuji G.

2019.2

Periostin links skin inflammation to melanoma progression in humans and mice. Reviewed International journal

Ohno F, Nakahara T, Kido-Nakahara M, Ito T, Nunomura S, Izuhara K, Furue M.

Int J Mol Sci.   2019.1

Differential efficacy of biologic treatments targeting the TNF-α/IL-23/IL-17 axis in psoriasis and psoriatic arthritis.[Review] Reviewed

2018.11

Darier's sign in urticaria pigmentosa-significance of perivascular eosinophilic infiltration. Reviewed International journal

Maehara E, Kido-Nakahara M, Ito T, Uchi H, Furue M.

Allergol Int   2018.10

Evaluation of mapping biopsies for extramammary Paget's disease: a retrospective study. Reviewed International journal

Kaku-Ito Y, Ito T (co-first), Tsuji G, Nakahara T, Uchi H, Hagihara A, Furue M.

J Am Acad Dermatol   2018.6

The diagnosis and management of extramammary Paget's disease.[Review] Invited Reviewed

Ito T*, Kaku-Ito Y, Furue M.

2018.6

Autoimmuity and autoimmune comorbidities in psoriasis.[Review] Reviewed

Furue K, Ito T, Tsuji G, Kadono T, Furue M.

2018.4

The role of the OVOL1-OVOL2 axis in normal and diseased human skin.[Review] Reviewed

Tsuji G, Ito T, Chiba T, Mitoma C, Nakahara T, Uchi H, Furue M.

2018.4

Melanoma and immune checkpoint inhibitors.[Review] Reviewed

Furue M, Ito T, Wada M, Wada N, Kadono T, Uchi H.

2018.4

A Novel Fusion Gene CRTC3-MAML2 in Hidradenoma: Clinicopathological and Histopathological Significance. Reviewed International journal

Kuma Y, Yamada Y, Yamamoto H, Kohashi K, Ito T, Furue M, Oda Y.

Hum Pathol   2017.12

CK1α ablation in keratinocytes induces p53-dependent, sunburn-protective skin hyperpigmentation. Reviewed International journal

2017.9

Alteration of PDGFRβ-Akt-mTOR Pathway Signaling in Fibrosarcomatous Transformation of Dermatofibrosarcoma Protuberans. Reviewed International journal

2017.9

Acral lentiginous melanoma versus other melanoma: a single-center analysis in Japan. Reviewed International journal

Wada M, Ito T, Tsuji G, Nakahara T, Uchi H, Hagihara A, Furue M.

J Dermatol   2017.8

Aryl hydrocarbon receptor activation restores filaggrin expression via OVOL1 in atopic dermatitis. Reviewed International journal

Tsuji G, Hashimoto-Hachiya A, Kiyomatsu-Oda M, Takemura M, Ohno F, Ito T, Morino-Koga S, Mitoma C, Nakahara T, Uchi H, Furue M.

Cell Death Dis   2017.7

HIF-1α, MDM2, CDK4, and p16 expression in ischemic fasciitis, focusing on its ischemic condition. Reviewed International journal

2017.7

Histological and immunohistochemical characteristics of undifferentiated small round cell sarcomas associated with CIC-DUX4 and BCOR-CCNB3 fusion genes. Reviewed International journal

Yamada Y, Kuda M, Kohashi K, Yamamoto H, Takemoto J, Ishii T, Iura K, Maekawa A, Bekki H, Ito T, Otsuka H, Kuroda M, Honda Y, Sumiyoshi S, Inoue T, Kinoshita N, Nishida A, Yamashita K, Ito I, Komune S, Taguchi T, Iwamoto Y, Oda Y.

Virchows Arch   2017.7

Potential role of the OVOL1-OVOL2 axis and c-Myc in the progression of cutaneous squamous cell carcinoma. Reviewed International journal

Ito T*, Tsuji G, Ohno F, Nakahara T, Uchi H, Furue M.

Mod Pathol   2017.6

Antioxidants for healthy skin: Emerging role of aryl hydrocarbon receptor and nuclear factor-erythroid 2-related factor-2.[Review] Reviewed

Furue M, Uchi H, Mitoma C, Hashimoto-Hachiya A, Chiba T, Ito T, Nakahara T, Tsuji G.

2017.3

Chronic spontaneous urticaria: implications of subcutaneous inflammatory cell infiltration in an intractable clinical course. Reviewed International journal

Itoh E, Nakahara T, Murata M, Ito T, Onozuka D, Furumura M, Hagihara A, Furue M.

J Allergy Clin Immunol   2017.1

Cutaneous angiosarcoma of the head and face: a single-center analysis of treatment outcomes in 43 patients in Japan. Reviewed International journal

Ito T*, Uchi H, Nakahara T, Tsuji G, Oda Y, Hagihara A, Furue M.

J Cancer Res Clin Oncol   2016.6

Prognostic significance of forkhead box M1 (FoxM1) expression and antitumor effect of FoxM1 inhibition in melanoma. Reviewed International journal

Ito T, Kohashi K, Yamada Y, Maekawa A, Kuda M, Furue M, Oda Y

Histopathology   2016.6

Activation of the OVOL1-OVOL2 Axis in the Hair Bulb and in Pilomatricoma. Reviewed International journal

Ito T*, Tsuji G, Uchi H, Nakahara T, Hashimoto-Hachiya A, Yoshida Y, Yamamoto O, Oda Y, Furue M.

Am J Pathol   2016.4

Prognostic Significance of Forkhead Box M1 (FOXM1) Expression and Antitumor Effect of FOXM1 Inhibition in Angiosarcoma. Reviewed International journal

Ito T, Kohashi K, Yamada Y, Iwasaki T, Maekawa A, Kuda M, Hoshina D, Abe R, Furue M, Oda Y.

J Cancer   2016.4

Narrow-margin excision is a safe, reliable treatment for well-defined, primary pigmented basal cell carcinoma: an analysis of 288 lesions in Japan. Reviewed International journal

Ito T*, Inatomi Y, Nagae K, Nakano-Nakamura M, Nakahara T, Furue M, Uchi H.

J Eur Acad Dermatol Venereol   2015.9

Triple-marker PCR assay of sentinel lymph node as a prognostic factor in melanoma. Reviewed International journal

Ito T*, Wada M, Nagae K, Nakano-Nakamura M, Nakahara T, Furue M, Uchi H.

J Eur Acad Dermatol Venereol   2015.5

Clinical characteristics associated with BRAF, NRAS and KIT mutations in Japanese melnoma patients. Reviewed International journal

Sakaizawa K, Ashida A, Uchiyama A, Ito T, Fujisawa Y, Ogata D, Matsushita S, Fujii K, Fukushima S, Shibayama Y, Hatta N, Takenouchi T, Uehara J, Okuyama R, Yamazaki N, Uhara H.

J Dermatol Sci   2015.4

Tumor thickness as a prognostic factor in extramammary Paget's disease. Reviewed International journal

Ito T*, Kaku Y, Nagae K, Nakano-Nakamura M, Nakahara T, Oda Y, Hagihara A, Furue M, Uchi H.

J Dermatol   2015.3

Acral lentiginous melanoma: Who benefits from sentinel lymph node biopsy? Reviewed International journal

Ito T*, Wada M, Nagae K, Nakano-Nakamura M, Nakahara T, Hagihara A, Furue M, Uchi H.

J Am Acad Dermatol   2015.1

Preferential expression of OVOL1 in inner root sheath of hair, sebaceous gland, eccrine duct and their neoplasms in human skin. Reviewed International journal

Mitoma C, Nakahara T, Uchi H, Ito T, Inatomi Y, Ide T, Jinnai S, Jinnai N, Iwasaki N, Sakamoto K, Kimura N, Maeda A, Kuma Y, Maehara E, Tsutsumi M, Kido-Nakahara M, Hirota T, Tamari M, Furue M.

Fukuoka Acta Med   105 ( 8 )   166 - 173   2014.8

Aberrant expression of S100A6 and matrix metalloproteinase 9, but not S100A2, S100A4, and S100A7, is associated with epidermal carcinogenesis. Reviewed International journal

Zhu L, Kohda F, Nakahara T, Chiba T, Tsuji G, Hachisuka J, Ito T, Tu Y, Moroi Y, Uchi H, Furue M.

J Dermatol Sci   2013.12

Upregulation of S100P, receptor for advanced glycation end products and ezrin in malignant melanoma. Reviewed International journal

Zhu L, Ito T, Nakahara T, Nagae K, Fuyuno Y, Nakao M, Akahosi M, Nakagawa R, Tu Y, Uchi H, Furue M.

J Dermatol   2013.12

The prognostic value of RT-PCR assay of sentinel lymph node biopsy for patients with cutaneous melanoma: A single center analysis in Japan. Reviewed International journal

Ito T*, Moroi Y, Oba J, Nakahara T, Takeuchi S, Uchi H, Takahara M, Masuda T, Furue M.

Melanoma Res   2012.1

Pigmented epithelioid melanocytoma arising from a teratoma of a Carney complex patient. Reviewed International journal

Toshio Ichiki, Takamichi Ito, Hiroko Oishi, Kiyoko Kato, Yoshinao Oda, Takeshi Nakahara

The Journal of Obstetrics and Gynaecology Research   2023.11

Subcutaneous Thyroid Tissue Implantation after Thyroidectomy: A Mimic of Benign Cutaneous Tumours. Reviewed International journal

Itsuki Takei, Takamichi Ito, Taro Mori, Yoshinao Oda, Takeshi Nakahara

Acta Dermato-Venereologica   103   adv00842   2023.1

Sudden and transient livedo reticularis as a manifestation of mononucleosis-like disease by cytomegalovirus Reviewed

Asuka Yokoyama, Takamichi Ito, Masutaka Furue

Clinical and Experimental Dermatology   46 ( 6 )   1158 - 1159   2021.8

Severe drug eruption induced by cyclin-dependent kinase 4 and 6 inhibitor Reviewed International journal

Hiroki Hashimoto, Takamichi Ito, Fumitaka Ohno, Hiromi Morisawa, Masutaka Furue

Journal of Dermatology   48 ( 7 )   e339 - e340   2021.7

Acral ischemia induced by nivolumab: A case report Reviewed

Asako Suenaga, Takamichi Ito, Ayaka Eto, Masutaka Furue

Journal of Dermatology   48 ( 5 )   e223 - e224   2021.5

Onychopapilloma presenting as longitudinal melanonychia: A case report and literature review Reviewed

Hiroki Hashimoto, Takamichi Ito, Yuichi Yamada, Yoshinao Oda, Masutaka Furue

Australasian Journal of Dermatology   62 ( 2 )   244 - 246   2021.5

Breast angiosarcoma without radiation history, putatively associated with subclinical lymphedema: A case report and review of the Japanese literature. Reviewed International journal

Maehara E, Mitoma C, Tsuji G, Ito T, Uchi H, Oda Y, Furue M.

J Dermatol   2017.10

Superficial CD34-positive fibroblastic tumor: A new case from Japan. Reviewed International journal

Wada N, Ito T, Uchi H, Nakahara T, Tsuji G, Ijichi A, Yamada Y, Oda Y, Furue M.

J Dermatol   2016.8

Onychopapilloma manifesting longitudinal melanonychia: a mimic of subungual malignancy. Reviewed International journal

Ito T*, Uchi H, Yamada Y, Oda Y, Furue M.

J Dermatol   2015.12

Evolution of a symptomatic diffuse developmental venous anomaly with progressive cerebral atrophy in an atypical case of Sturge-Weber syndrome. Reviewed International journal

Ohno K, Saito Y, Togawa M, Shinohara Y, Ito T, Sugano H, Itamura S, Nishimura Y, Tamasaki A, Maegaki Y.

Brain Dev   2015.9

Two cases of cutaneous squamous cell carcinoma arising in immunosppressed patients with chronic human papillomavirus infection. Reviewed International journal

Kuma Y, Ito T, Nagae K, Mizote Y, Nakahara T, Uchi H, Yamada Y, Okura M, Oda Y, Yamashita T, Furue M.

Case Rep Dermatol   2015.7

Linear and whorled nevoid hypermelanosis with severe tetralogy of Fallot. Reviewed International journal

Ito T*, Yoshida Y, Goto H, Furue M, Yamamoto O

Indian J Dermatol   60 ( 3 )   325 - 325   2015.5

Tonic water-induced generalized bullous fixed eruption. Reviewed International journal

Kaku Y, Ito T, Wada M, Nozaki Y, Kido-Nakahara M, Furue M.

Acta Derm Venereol   2015.4

Disseminated protothecosis manifesting with multiple, rapidly-progressing skin ulcers: successful treatment with anphotericin B. Reviewed International journal

Murata M, Ito T, Nagae K, Nakano-Nakamura M, Nishida R, Takei K, Takahara M, Uchi H, Nishimura K, Masuda M, Furue M.

Eur J Dermatol   2015.4

Osteomalacia induced by a phosphaturic mesenchymal tumor secreting fibroblast growth factor 23. Reviewed International journal

Nagae K, Uchi H, Ito T, Moroi Y, Oda Y, Furue M.

Eur J Dermatol   2015.4

Poroma with sebaceous differentiation– dermoscopy for the diagnosis of skin tumor with sebaceous differentiation. Reviewed International journal

2015.1

Pigmented Bowen’s disease with prominent amyloid deposition on the eyelid. Reviewed International journal

2014.11

Increased expression of S100A6 in malignant granular cell tumors. Reviewed International journal

Mitamura Y, Ito T, Nakano-Nakamura M, Uchi H, Moroi Y, Furue M.

Acta Derm Venereol   2014.9

Dermoscopic feature of polypoid epidermal cyst. Reviewed International journal

Ito T*, Yoshida Y, Furue M, Yamamoto O.

Australas J Dermatol   2014.5

Lipoblastomatosis on the sole showing spontaneous regression. Reviewed International journal

Ito T*, Itoh E, Koda-Maeda A, Kiryu H, Yamada Y, Yamashita T, Oda Y, Furue M

Eur J Dermatol   2014.5

Hybrid perineurioma-neurofibroma in a patient with neurofibromatosis type 1, clinically mimicking malignant peripheral nerve sheath tumor. Reviewed International journal

Inatomi Y, Ito T*, Nagae K, Yamada Y, Kiyomatsu M, Nakano-Nakamura M, Uchi H, Oda Y, Furue M.

Eur J Dermatol   2014.5

Generalized fixed drug eruption induced by tranexamic acid. Reviewed International journal

Kaku Y, Ito T, Kudo K, Kido-Nakahara M, Nakahara T, Moroi Y, Furue M.

Eur J Dermatol   2014.5

S100A6 and c-kit-positive spindle cell melanoma of the dorsal foot. Reviewed International journal

Mitamura Y, Ito T, Nakano-Nakamura M, Uchi H, Furue M

Case Rep Dermatol   2014.5

Four cases of successfully treated chronic expanding soft tissue hematoma Reviewed International journal

Ito T*, Nakahara T, Takeuchi S, Uchi H, Takahara M, Masuda T, Moroi Y, Furue M.

Ann Dermatol   2014.2

Dermoscopy of peristomal polyps and metastases. Reviewed International journal

Ito T*, Yoshida Y, Yamada N, Furue M, Yamamoto O.

Acta Derm Venereol   2014.1

Marked melanocyte colonization in a pigmented Sister Mary Joseph's nodule from intrahepatic cholangiocarcinoma. Reviewed International journal

Higuchi M, Shibata-Kikuchi S, Ito T, Gondo C, Takahara M, Moroi Y, Furue M.

Eur J Dermatol   2014.1

Disseminated skin lesions of IgG4-related disease. Reviewed International journal

Ito T*, Yoshida Y, Adachi K, Furue M, Yamamoto O

Eur J Dermatol   2013.7

Antiphospholipid Syndrome Complicated by Unilateral Pleural Effusion. Reviewed International journal

Mitamura Y, Takahara M, Ito T, Nakano M, Moroi Y, Furue M.

Case Rep Dermatol   2013.7

Bilateral nevus comedonicus syndrome. Reviewed International journal

Ito T*, Mitamura Y, Tsuji Y, Harada K, Urabe K.

Yonago Acta Med   2013.6

Solitary nodule on the nose: A Quiz. Reviewed International journal

Ito T*, Yoshida Y, Furue M, Yamamoto O.

Acta Derm Venereol   2013.5

Unique dermoscopic findings of penile Mondor's disease. Reviewed International journal

Ito T*, Yoshida Y, Goto H, Yamada N, Furue M, Yamamoto O

Eur J Dermatol   23 ( 3 )   422 - 3   2013.5

Trichoblastoma shares cytokeratin 15-positive cells with seborrheic keratosis in a composite tumor – novel immunohistochemical findings. Reviewed International journal

2013.4

Subcutaneous benign fibrous histiocytoma showing nerve involvement on the eyebrow region. Reviewed International journal

Ito T*, Yoshida Y, Furue M, Yamamoto O.

Acta Derm Venereol   2013.1

Wart with depigmented halo and generalized vitiligo. Reviewed International journal

Ito T*, Yoshida Y, Adachi K, Furue M, Yamamoto O.

Yonago Acta Med   2012.12

Multiple congenital comedones, hearing impairment and intellectual disability: a new syndromic association? Reviewed International journal

Ito T*, Yoshida Y, Furue M, Yamamoto O.

Eur J Dermatol   2012.11

Dermoscopic feature of reticulated acanthoma (superficial epithelioma) with sebaceous differentiation. Reviewed International journal

Ito T*, Yoshida Y, Furue M, Yamamoto O.

Eur J Dermatol   2012.9

【特別講演】 皮膚リンパ腫の診断と治療 Invited

伊東孝通

福岡地区皮膚科医会 第45回総会・学術講演会 福岡市  2023.4 

【教育講演】メラノサイト系腫瘍における免疫染色の意義 Invited

伊東孝通

第121回 日本皮膚科学会総会  2022.6 

皮膚がんのステージ分類 Invited

伊東 孝通

福岡県院内がん登録研修会  2020.2 

【教育講演】メラノーマの治療 Up-dated Invited

伊東 孝通

第391回 日本皮膚科学会福岡地方会  2019.11 

【教育講演】色素細胞腫瘍 Invited

伊東 孝通

第118回 日本皮膚科学会総会  2019.6 

【病理シンポジウム】メラノーマのReal World Invited

伊東 孝通

第71回日本皮膚科学会西部支部学術大会  2019.9 

H30年度 日本皮膚科学会 基礎医学研究費（資生堂寄付） 研究結果報告会 Invited

伊東 孝通, 村田 真帆 古江 増隆

第118回 日本皮膚科学会総会  2019.6 

【教育講演】メラノーマの外科治療の基本 Invited

伊東孝通

第70回 日本皮膚科学会西部支部学術集会  2018.11 

Prognostic significance of forkhead box M1 (FOXM1) expression and antitumor effect of FOXM1 inhibition in melanoma. International conference

Ito T, Kohashi K, Yamada Y, Furue M, Oda Y.

International Investigative Dermatology 2018  2018.5 

Potential role of the OVOL1-OVOL2 axis and c-Myc in the progression of cutaneous squamous cell carcinoma from Bowen's disease. International conference

Ito T, Tsuji G, Ohno F, Nakahara T, Uchi H, Furue M.

The 76th Annual Meeting of the Society for Investigative Dermatology.  2017.4 

【The 17th Galderma Award】Acral lentiginous melanoma: Who benefits from sentinel lymph node biopsy? Invited International conference

2016.12 

【アブストラクト賞】毛髪に発現する新規転写因子OVOL1/2の調節機構

伊東孝通, 辻学, 大野文嵩, 内博史, 中原剛士, 古江増隆

第34回 美容皮膚科学会総会  2016.8 

【ポスター賞】頭部血管肉腫の生存解析

伊東孝通, 内博史, 中原剛士, 辻学, 古江増隆

第115回 日本皮膚科学会総会  2016.6 

【アブストラクト賞】末端黒子型悪性黒色腫においてセンチネルリンパ節生検を施行すべき条件について

伊東孝通, 和田麻衣子, 永江航之介, 中村美沙, 中原剛士, 萩原明人, 古江増隆, 内博史

第114回 日本皮膚科学会総会  2015.5 

Interesting educational cases: a red nodule on the forehead of an 83-year-old woman. Invited International conference

Ito T, Yamamoto O, Oda Y, Furue M.

The 3rd Eastern Asia Dermatology Congress. 2014/09/24-26. Jeju, Korea  2014.9 

Yellow plaque on the chest. Invited International conference

Ito T, Yoshida Y, Furue M, Yamamoto O

The 12th Korean Dermatopathology Symposium  2013.5 

【ポスター賞】当科における悪性黒色腫センチネルリンパ節生検の検討

伊東孝通, 中原剛士, 城戸真希子, 内博史, 高原正和, 増田禎一, 師井洋一, 古江増隆.

第109回日本皮膚科学会総会  2010.4 

[Invited Lecture] Nail apparatus melanoma: Current management and future perspectives. Invited

Ito T

The 8th Annual Meeting of Korean Nail Society. 2023/10/14. Seoul, Korea  2023.10 

Real-world outcomes of Asian patients with advanced BRAF-mutant melanoma treated with first-line BRAF/MEK inhibitors, anti- PD-1 monotherapy, or combination of nivolumab plus ipilimumab: A multicenter retrospective study in Japan (B-CHECK- RWD study).

Namikawa K, Ito T, Yoshikawa S, Yoshino K, Kiniwa Y, Takenouchi T, Kato H, Mizuhashi S, Yamamoto Y, Fujisawa Y, Yamasaki O, Nakamura Y, Asai J, Maekawa T, Matsushita S, Nakano E, Oashi K, Uhara H, Miyagawa T, Yamazaki N

2022 American Society of Clinical Oncology (ASCO) Annual Meeting. 2022/6/3-7, Chicago. USA  2022.6 

【受賞講演】掌蹠メラノーマのBRAF変異の実際 免疫組織学的検討 Invited

伊東孝通

第37回 日本皮膚病理組織学会総会・学術大会  2021.4 

【ランチョンセミナー】BRAF陽性メラノーマの治療選択と副作用マネジメント Invited

伊東孝通

第37回 日本皮膚悪性腫瘍学会学術大会  2021.7 

【教育実習セミナー】皮膚病理：境界部皮膚炎 Interface Dermatitis Invited

伊東孝通

第120回日本皮膚科学会総会  2021.6 

皮膚がんの薬物療法 Invited

伊東孝通

福岡市がん専門薬剤師集中教育講座  2020.12 

Human epidermal growth factor receptor 3 regulates anchorage-independent growth of acral melanoma cells and serves as a novel therapeutic target.

Tanaka Y, Ito T, Tanegashima K, Kido-Nakahara M, Nakahara T

The 1st International Societies for Investigative Dermatology Meeting, Tokyo, Japan  2023.5 

Concordance in judgment of clinical borders of basal cell carcinomas in Japanese patients.

Kamimura A, Nakamura Y, Matsushita S, Fujisawa Y, Matsuya T, Maeda T, Uhara H, Oashi K, Yanagisawa H, Yoshino K, Funakoshi T, Miyagawa T, Takenouchi T, Hatta N, Kiniwa Y, Kiyohara Y, Yokota K, Isei T, Uchi H, Shibayama Y, Ito T, Fukushima S, Yamazaki N

The 18th European Association of Dermato-Oncology Congress. 2022/4/21-23, Seville, Spain.  2022.4 

Confirmatory trial of narrower side margin excision for head and neck basal cell carcinoma in the Japanese (East Asian) population: JCOG2005 (J-BASE-MARGIN).

Nakamura Y, Sano Y, Kataoka T, Shibata T, Fukuda H, Matsushita S, Fujisawa Y, Takenouchi T, Omodaka T, Yamamura K, Aoki M, Uchi H, Tsutsui K, Yoshikawa S, Ogata D, Yanagisawa H, Omatsu J, Ito T, Namikawa K, Yamazaki N

2022 American Society of Clinical Oncology (ASCO) Annual Meeting. 2022/6/3-7, Chicago. USA  2022.6 

Nectin cell adhesion molecule 4 regulates angiogenesis and serves as a novel therapeutic target in angiosarcoma.

Tanaka Y, Ito T, Tanegashima K, Tsuji G, Nakahara M, Nakahara T

The 47th Annual Meeting of the Japanese Society for Investigative Dermatology. 2022/12/2-4, Nagasaki, Japan  2022.12 

NF1の叢状神経線維腫に対するセルメチニブの使用経験

伊東孝通, 一木稔生, 中原剛士

第141回日本皮膚科学会山陰地方会 2023/09/2-3 米子市  2023.9 

免疫チェックポイント阻害剤による皮膚障害 Invited

伊東孝通

中外 Web Seminar on Breast Cancer 2020.9.4 福岡市  2020.9 

日本人メラノーマのBRAF変異の実際とマネジメント Invited

伊東孝通

Novartis Melanoma Web Seminar 2019.12.13 東京都  2019.12 

Reticulated acanthoma with sebaceous differentiation: unique dermoscopic findings. International conference

Ito T, Yoshida Y, Furue M, Yamamoto O

The 10th Meeting of the German-Japanese Society of Dermatology  2012.12 

CT angiography imaging for free flap breast reconstruction: Usefulness in preoperative planning. International conference

Ito T, Takagi S, Ohyama T, Sakai K, Eto A, Yamazumi K, Tajiri T, Onozawa H, Ohjimi H

The 21st Japan-China Joint Congress on Plastic Surgery  2011.11 

irAEマネジメント 皮膚障害について Invited

伊東孝通

2022.10 

メラノーマの治療戦略 update. Invited

伊東孝通

2022.10 

メラノーマ診療の今 ～患者さんに最善の医療を届けるために～ Invited

伊東孝通

メラノーマを見逃さないために！ ノバルティス株式会社講演会 2022/03/22 Web  2022.3 

創傷の病態と治療 Invited

伊東孝通

2021年度 皮膚・排泄ケア認定看護師教育過程 講義 2022/05/31 福岡市  2022.5 

病理組織から臨床研究を着想する ～皮膚希少がんに対する抗体薬物複合体の可能性～ Invited

伊東孝通

環中海皮膚病理組織研究会 2022/12/15 米子市  2022.12 

皮膚リンパ腫 Invited

伊東孝通

Meiji社内講演会 2022/2/22 WEB  2022.2 

皮膚外科の基本と応用 Invited

伊東孝通

筑豊エリア皮膚科講演会 2022/12/20 WEB  2022.12 

鑑別/診断から治療におけるピットホール：メラノーマ Invited

伊東孝通

2022.8 

BRAF/MEKi CR中止後に再発した1例 Invited

伊東孝通

2021.9 

CRを目指すBRAF陽性メラノーマの治療選択 Invited

伊東孝通

2021.6 

メラノーマ診療 Beyond the Guidelines Invited

伊東孝通

肥前皮膚腫瘍カンファレンス 2021/08/04 Web  2021.8 

メラノーマ診療のキホン Invited

伊東孝通

第2回 マルホDermatology Online Seminar 2021/02/01 WEB  2021.2 

創傷の病態と治療 Invited

伊東孝通

2021年度 皮膚・排泄ケア認定看護師教育過程 講義 2021/05/31 福岡市  2021.5 

悪性黒色腫の術後補助療法 当院での治療経験を踏まえて Invited

伊東孝通

2021.4 

日々の疑問を臨床研究で解決する Invited

伊東孝通

2021.7 

臨床研究のすゝめ Invited

伊東孝通

2021.11 

逆算思考の切除縫縮 Invited

伊東孝通

第5回マルホDermatology Online Seminar WEB  2021.7 

BRAF変異陽性進行期メラノーマの治療戦略～何が問題なのか？～ Invited

伊東孝通

ノバルティス 社内講演会 2020.8.3 福岡市  2020.8 

皮膚腫瘍

伊東孝通

第349回 九州沖縄スライドコンファレンス 2016/01/30 北九州市  2016.1 

血管肉腫におけるFOXM1発現と治療ターゲットとしての可能性

伊東孝通, 孝橋賢一, 山田裕一, 岩崎健, 前川啓, 久田正昭, 古江増隆, 小田義直

第105回 日本病理学会総会 2016/05/12-15 仙台市  2016.12 

頭部血管肉腫の生存解析

伊東孝通, 内博史, 中原剛士, 辻学, 古江増隆

第115回 日本皮膚科学会総会 2016/06/03-05 京都府  2016.6 

爪甲色素線条を呈したonychopapillomaの1例

伊東孝通, 内博史, 山田裕一, 小田義直, 古江増隆

第31回 日本皮膚悪性腫瘍学会学術大会 2015/07/04 大阪府  2015.7 

境界明瞭な基底細胞癌の切除マージンは2mmで十分である: 288例の検討

伊東孝通, 稲富裕祐, 永江航之介, 中村美沙, 中原剛士, 古江増隆, 内博史

第66回 日本皮膚科学会 西部支部学術集会 2014/11/8-9 高松市  2014.11 

著明なアミロイド沈着を伴った眼瞼の色素性ボーエン病

伊東孝通, 和田麻衣子, 隈有希, 中原真希子, 山田裕一, 岡野慎士, 小田義直, 古江増隆

第30回皮膚悪性腫瘍学会 2014/07/4-5 東京都  2014.7 

ストーマ周囲に生じた大腸がん皮膚転移と過形成ポリープのダーモスコピー所見

伊東孝通, 吉田雄一, 古江増隆, 山元修

第29回 皮膚悪性腫瘍学会 学術集会 2013/08/9-10 甲府市  2013.8 

脂腺分化を伴った汗孔腫の1例とそのダーモスコピー所見

伊東孝通, 吉田雄一, 山元修

第9回山陰皮膚疾患研究会 2013/03/14 松江市  2013.3 

遊離皮弁におけるMDCTの有用性と限界 CTA評価と術中所見との比較

伊東孝通, 高木誠司, 大山拓人, 衛藤明子, 酒井邦夫, 山住賢司, 田尻豊和, 小野澤久輔, 古江増隆, 大慈弥裕之

第1回日本乳房オンコプラスティックサージャリー学会総会 2013/09/19-20 福岡市  2013.9 

IgG4関連疾患の皮疹が播種性にみられた1例

伊東孝通, 吉田雄一, 古江増隆, 山元修

第364回 日本皮膚科学会 福岡地方会 2012/03/23 福岡市  2012.3 

Superficial epithelioma with sebaceous differentiationの1例とその形態学的考察

伊東孝通, 吉田雄一, 古江増隆, 山元修

第64回日本皮膚科学会 西部支部学術大会 2012/10/27-28 広島市  2012.10 

進行期メラノーマの治療戦略 Invited

伊東孝通

Melanoma Experts Seminar 2023/03/11 東京都  2023.3 

Interface Dermatitis Invited

2019.4 

irAE皮膚障害を知る Invited

伊東孝通

中外eセミナー on lung cancer in Kyushu 2023/06/14 WEB  2023.6 

メラノーマ再発時治療戦略 Up-to-Date Invited

伊東孝通

2023.5 

外陰部粘膜メラノーマの肺転移を切除しPD-1アジュバント完遂後に肝転移をきたした1例 Invited

伊東孝通

Melanoma New Generation Specialists Forum 2023/08/25 東京都  2023.8 

皮膚悪性腫瘍に対する抗体薬物複合体治療の可能性とBRAF陽性メラノーマの治療戦略 Invited

伊東孝通

東北皮膚悪性腫瘍カンファレンス 2023/05/19 WEB  2023.5 

【皮膚悪性腫瘍(第2版)上-基礎と臨床の最新研究動向-】メラノーマ メラノーマの検査・診断 病理組織検査 BRAF遺伝子変異検査（総説） Reviewed

伊東 孝通

日本臨床   2021.5

BRAF heterogeneity of melanoma. Reviewed

Ito T*, Tanaka Y, Murata M, Kaku-Ito Y, Furue K, Furue M.

Curr Treat Option Oncol. 22: 20., 2021   2021.4

【これでわかる 婦人科稀少腫瘍】外陰腫瘍 乳房外パジェット病（総説） Reviewed

伊東 孝通

産科と婦人科   2021.2

Japanese Dermatological Association Guidelines: Outlines of guidelines for cutaneous melanoma 2019. Reviewed

Nakamura Y, Asai J, Igaki H, Inozume T, Namikawa K, Hayashi A, Fukushima S, Fujimura T, Ito T, Imafuku K, Tanaka R, Teramoto Y, Minagawa A, Miyagawa T, Miyashita A, Wada M, Koga H, Sugaya M.

2020.9

The CCL20 and CCR6 axis in psoriasis. Reviewed

Furue K, Ito T, Tsuji G, Nakahara T, Furue M.

Scand J Immunol. 91: e12846, 2020. doi: 10.1111/sji.12846.   2020.4

Pathogenic implication of epidermal scratch injury in psoriasis and atopic dermatitis. Reviewed

Furue K, Ulzii D, Tanaka Y, Ito T, Tsuji G, Kido-Nakahara M, Nakahara T, Furue M.

J Dermatol 47: 979-988, 2020.   2020.4

Adjuvant Therapy for Melanoma. Reviewed

Wada-Ohno M, Ito T, Furue M.

Curr Treat Options Oncol.   2019.9

日本皮膚科学会ガイドライン 皮膚悪性腫瘍ガイドライン第3版 メラノーマ診療ガイドライン2019 Reviewed

中村 泰大, 浅井 純, 井垣 浩, 猪爪 隆史, 並川 健二郎, 林 礼人, 福島 聡, 藤村 卓, 伊東 孝通, 今福 惠輔, 田中 亮多, 寺本 由紀子, 皆川 茜, 宮川 卓也, 宮下 梓, 和田 誠, 古賀 弘志, 菅谷 誠, 公益社団法人日本皮膚科学会, 一般社団法人日本皮膚悪性腫瘍学会, 皮膚悪性腫瘍診療ガイドライン改訂委員会(メラノーマ診療ガイドライングループ)

日本皮膚科学会雑誌   2019.8

The diagnosis and management of extramammary Paget's disease.

Ito T*, Kaku-Ito Y, Furue M.

Expert Rev Anticancer Ther   2018.6

Melanoma and Non-Melanoma Skin Cancers メラノーマ・皮膚癌 メラノーマのセンチネルリンパ節生検 海外臨床試験の概説（総説） Reviewed

伊東 孝通, 中原 剛士, 師井 洋一

癌と化学療法   2010.4

術後30年以上経過し再発した悪性黒色腫の2例

松永 拓磨, 加登本 晶子, 伊東 孝通

西日本皮膚科   2022.8

【アトピー性皮膚炎の最新情報と新治療】既存治療に難治であったが,デルゴシチニブ外用により痒みが改善したアトピー性皮膚炎

橋本 弘規, 伊東 孝通, 一木 稔生, 末永 亜紗子, 中原 剛士

皮膚病診療   2022.8

日光曝露を契機として水疱性類天疱瘡を合併したと考えられた尋常性乾癬の1例

松永 拓磨, 佐々木 諒, 伊東 孝通, 古賀 浩嗣, 石井 文人, 古江 増隆

西日本皮膚科   2022.8

腹膜合併切除を行った鼠径部異所性子宮内膜症の1例

橋本 弘規, 江藤 綾桂, 末永 亜紗子, 大野 麻衣子, 伊東 孝通, 中原 剛士

日本皮膚外科学会誌   2022.7

犬咬傷後に広範な皮下気腫がみられガス壊疽との鑑別を要した1例

藤井 晴香, 伊東 孝通, 佐々木 諒

西日本皮膚科   2022.6

抗PD-1抗体によるメラノーマ術後補助療法の有効性・安全性の検証 多施設共同研究

武藤 雄介, 加藤 裕史, 福島 聡, 伊東 孝通, 前川 武雄, 藤澤 康弘, 吉野 公二, 内 博史, 松下 茂人, 藤村 卓

日本皮膚科学会雑誌   2022.5

硬性浮腫を呈したdigital papillary adenocarcinomaの皮膚転移の1例

大野 文嵩, 大野 麻衣子, 伊東 孝通, 中原 剛士

西日本皮膚科   2022.2

日光黒子内に発生したTrichoblastomaとEccrine Poromaの合併例

隈 有希, 一木 稔生, 伊東 孝通, 吉田 舞子, 桐生 美麿, 古江 増隆

西日本皮膚科   2022.2

進行期メラノーマに対するファーストラインでのニボルマブ・イピリムマブ併用療法の効果についての検討

藤澤 康弘, 並川 健二郎, 前川 武雄, 吉野 公二, 木庭 幸子, 伊東 孝通, 加藤 裕史, 松下 茂人, 寺本 由紀子, 吉川 周佐

日本皮膚悪性腫瘍学会学術大会プログラム・抄録集   2021.6

手背に生じたMyxoinflammatory Fibroblastic Sarcomaの1例

橋本 弘規, 大野 文嵩, 伊東 孝通, 大野 麻衣子, 塩道 泰子, 森澤 紘美, 一木 稔生, 山田 裕一, 小田 義直, 古江 増隆

西日本皮膚科   2021.6

進行期黒色腫に対するエンコラフェニブ,ビニメチニブ併用療法 22例の多施設共同後ろ向き解析

大内 謙太郎, 吉野 公二, 加藤 裕史, 藤澤 康弘, 山本 有紀, 伊東 孝通, 松下 茂人, 前川 武雄, 相場 節也, 藤村 卓

日本皮膚科学会雑誌   2021.5

肛囲への表皮内進展を伴う直腸/肛門管癌の2例 CDX2染色の診断学的意義

橋本 弘規, 辻 学, 永江 航之介, 仲本 すみれ, 江藤 綾桂, 大野 文嵩, 大野 麻衣子, 伊東 孝通, 中原 剛士, 古江 増隆

西日本皮膚科   2021.2

頭部巨大基底細胞癌の1例

橋本 弘規, 江藤 綾桂, 永江 航之介, 仲本 すみれ, 佐藤 友紀, 大野 文嵩, 大野 麻衣子, 伊東 孝通, 古江 増隆

西日本皮膚科   2020.12

本邦メラノーマにおけるBRAF/MEK阻害剤併用療法の効果についての多施設共同研究:102例の解析

藤澤 康弘, 伊東 孝通, 加藤 裕史, 入江 浩之, 加持 達弥, 前川 武雄, 浅井 純, 山本 有紀, 藤村 卓, 吉野 公二

日本皮膚悪性腫瘍学会学術大会プログラム・抄録集   2020.12

【潰瘍をきたす疾患】脂腺癌 Muir-Torre症候群

藤井 晴香, 井手 豪俊, 佐々木 諒, 大野 麻衣子, 伊東 孝通, 古江 増隆

皮膚病診療   2020.11

本邦メラノーマにおけるBRAF/MEK阻害剤併用の効果についての多施設共同研究

藤澤 康弘, 吉野 公二, 加藤 裕史, 入江 浩之, 加持 達弥, 前川 武雄, 浅井 純, 山本 有紀, 藤村 卓, 安田 正人, 松山 かなこ, 武藤 一考, 松下 茂人, 内 博史, 伊東 孝通

日本皮膚科学会雑誌   2020.8

Pachydermoperiostosisの1例

井手 豪俊, 大野 麻衣子, 塚本 華倫, 木村 七絵, 伊東 孝通, 平野 敦士, 古江 増隆

臨床皮膚科   2020.2

The CCL20 and CCR6 axis in psoriasis. Reviewed

Furue K, Ito T, Tsuji G, Nakahara T, Furue M.

Scand J Immunol.   2019.12

The IL-13-OVOL1-FLG axis in atopic dermatitis. Reviewed

Furue K, Ito T, Tsuji G, Ulzii D, Vu YH, Kido-Nakahara M, Nakahara T, Furue M.

Immunology.   2019.11

右鼠径部に生じ子宮円索との連続性を認めた子宮内膜症の1例

堤 碧, 中村 美沙, 伊東 孝通, 西田 陽登, 古江 増隆

西日本皮膚科   2019.10

Does mechanical scratching cause the recruitment of T-helper 17 cells in atopic dermatitis? Reviewed

Furue K, Ito T, Tsuji G, Esaki H, Kido-Nakahara M, Nakahara T, Furue M.

J Dermatol   2019.10

血清IL-6の上昇を認めた続発性ヘモクロマトーシスの1例

堤 碧, 中村 美沙, 河津 宗太郎, 伊東 孝通, 古江 増隆

西日本皮膚科   2019.4

Implications of tryptophan photoproduct FICZ in oxidative stress and terminal differentiation of keratinocytes.

Furue M, Uchi H, Mitoma C, Hashimoto-Hachiya A, Tanaka Y, Ito T, Tsuji G.

G Ital Dermatol Venereol   2019.2

【血液疾患と皮膚病】臨床例 結節性紅斑を伴った真性多血症

堤 碧, 中村 美沙, 伊東 孝通, 古江 増隆

皮膚病診療   2018.11

Differential efficacy of biologic treatments targeting the TNF-α/IL-23/IL-17 axis in psoriasis and psoriatic arthritis.

2018.11

HidradenomaにおけるCRTC1/3-MAML2融合遺伝子の発現と臨床病理学的検討

隈 有希, 山田 裕一, 山元 英崇, 孝橋 賢一, 伊東 孝通, 古江 増隆, 小田 義直

日本病理学会会誌   2018.4

Melanoma and immune checkpoint inhibitors.

Furue M, Ito T, Wada M, Wada N, Kadono T, Uchi H.

Curr Oncol Rep   2018.4

Autoimmuity and autoimmune comorbidities in psoriasis.

Furue K, Ito T, Tsuji G, Kadono T, Furue M.

Immunology   2018.4

The role of the OVOL1-OVOL2 axis in normal and diseased human skin.

Tsuji G, Ito T, Chiba T, Mitoma C, Nakahara T, Uchi H, Furue M.

J Dermatol Sci   2018.4

皮膚疾患における転写因子OVOL1-OVOL2の働き

辻 学, 伊東 孝通, 古江 増隆

西日本皮膚科   2017.12

爪甲剥離症を合併したTerry's Nail

堤 碧, 伊東 孝通, 安河内 由美, 内 博史, 古江 増隆

西日本皮膚科   2017.4

Digital Papillary Adenocarcinomaの1例

和田 尚子, 内 博史, 伊東 孝通, 桐生 美麿, 古江 増隆

西日本皮膚科   2017.4

Antioxidants for healthy skin: Emerging role of aryl hydrocarbon receptor and nuclear factor-erythroid 2-related factor-2.

Furue M, Uchi H, Mitoma C, Hashimoto-Hachiya A, Chiba T, Ito T, Nakahara T, Tsuji G.

2017.3

脱分化型脂肪肉腫と鑑別を要した未分化多形肉腫の1例

宮崎 玲子, 内 博史, 伊東 孝通, 石井 武彰, 山田 裕一, 小田 義直, 古江 増隆

西日本皮膚科   2017.2

多発性基底細胞癌の1例

増田 亜希子, 伊東 孝通, 和田 麻衣子, 加来 裕美子, 中村 美沙, 内 博史, 古江 増隆

西日本皮膚科   2016.12

全身性エリテマトーデス、Sjoegren症候群に併発した多発性皮膚線維腫の1例

堤 碧, 伊東 孝通, 河原 紗穂, 安河内 由美, 内 博史, 古江 増隆

西日本皮膚科   2016.10

精漿アレルギー(Human Seminal Plasma Allergy)の1例

増田 亜希子, 伊東 孝通, 和田 麻衣子, 日高 らん, 古江 増隆

西日本皮膚科   2016.8

Basaloid Follicular Hamartomaの1例

宇佐川 祐子, 三苫 千景, 伊東 孝通, 伊藤 さおり, 桐生 美麿, 内 博史, 古江 増隆

福岡医学雑誌   2016.8

血管肉腫におけるFOXM1発現と治療ターゲットとしての可能性

伊東 孝通, 孝橋 賢一, 山田 裕一, 岩崎 健, 前川 啓, 久田 正昭, 古江 増隆, 小田 義直

日本病理学会会誌   2016.4

顔面頭部に多発した偽リンパ腫の1例

井手 豪俊, 竹井 賢二郎, 池田 真希, 伊東 孝通, 桐生 美麿, 古江 増隆

西日本皮膚科   2016.2

進行性顔面片側萎縮症

堤 碧, 伊東 孝通, 伊藤 絵里子, 古江 増隆

西日本皮膚科   2015.12

皮膚にアミロイド蛋白の沈着を認めた全身性アミロイドーシスの2例

堤 碧, 三苫 千景, 伊東 孝通, 加来 裕美子, 伊藤 さおり, 中原 真希子, 古江 増隆

西日本皮膚科   2015.8

貧血母斑を伴ったPseudo-Human Tailの1例

和田 麻衣子, 伊東 孝通, 中原 真希子, 橋口 公章, 古江 増隆

西日本皮膚科   2015.6

老人性血管腫内ではなく皮下組織の血管に腫瘍性B細胞を認めたintravascular large B-cell lymphomaの1例

和田 麻衣子, 伊東 孝通, 中村 美沙, 内 博史, 古江 増隆, 阿部 篤, 新垣 克実, 平橋 美奈子, 山元 英崇, 小田 義直, 土師 正二郎

西日本皮膚科   2015.6

日本人の悪性黒色腫のBRAF、NRAS、KIT変異率と臨床所見 Reviewed

境澤 香里, 芦田 敦子, 伊東 孝通, 藤澤 康弘, 緒方 大, 松下 茂人, 藤井 一恭, 福島 聡, 柴山 慶継, 八田 尚人, 竹之内 辰也, 上原 治朗, 奥山 隆平, 山崎 直也, 宇原 久

日本皮膚科学会雑誌   2015.4

右踵に生じたDesmoplastic Malignant Melanomaの1例

隈 有希, 伊東 孝通, 和田 麻衣子, 日高 らん, 中村 美沙, 内 博史, 古江 増隆

皮膚科の臨床   2015.4

耳垂に生じた毛母腫の2例

池田 真希, 伊東 孝通, 栗原 雄一, 内 博史, 師井 洋一, 古江 増隆

臨床皮膚科   2014.11

エキシマライト療法の効果を認めた小児蛇行状脱毛症の1例

和田 麻衣子, 里村 暁子, 伊東 孝通, 高原 正和, 古江 増隆

西日本皮膚科   2014.10

著明なアミロイド沈着を伴った眼瞼の色素性ボーエン病 Reviewed

伊東 孝通, 和田 麻衣子, 隈 有希, 中原 真希子, 山田 裕一, 岡野 慎士, 小田 義直, 古江 増隆

日本皮膚悪性腫瘍学会学術大会プログラム・抄録集   2014.7

Benign Symmetrical Lipomatosis

2014.4

急性骨髄性白血病に先行してみられた皮膚サルコイド反応の1例

三田村 康貴, 伊東 孝通, 原田 佳代, 占部 和敬, 門脇 賢典, 岡村 精一, 古江 増隆

西日本皮膚科   2013.4

Coccygeal Pad

2012.6

Rippled-Pattern Sebaceomaの2例

伊東 孝通, 三田村 康貴, 辻 弥生, 原田 佳代, 占部 和敬, 桐生 美麿

皮膚科の臨床   2012.2

【爪および爪周辺の疾患】臨床例 手指爪下に生じた有棘細胞癌

伊東 孝通, 田代 あかり, 吉村 映里, 城戸 真希子, 中原 剛士, 高原 正和, 師井 洋一, 古江 増隆

皮膚病診療   2011.3

Morphea様の皮膚病変を伴いステロイド全身投与に治療抵抗性を示した好酸球性筋膜炎の1例

伊東 孝通, 桑原 健太郎, 増野 年彦

皮膚科の臨床   2010.4

生下時より後頭部に皮疹を認めたAngioblastoma(中川)の1例

伊東 孝通, 桑原 健太郎, 増野 年彦

皮膚科の臨床   2009.7

Psoriasis and the TNF/IL23/IL17 axis.

Furue K, Ito T, Tsuji G, Kadono T, Furue M.

G Ital Dermatol Venereol.   1900

The Japan Dermatohistopathology Society [Trustee]

The Japanese Society of Plastic and Reconstructive Surgery

The Japanese Skin Cancer Society

The Japanese Dermatological Association [Representative]

Current Treatment Options in Oncology International contribution

2018.1 - Present

Screening of academic papers

Role(s)： Peer review

2018

Screening of academic papers

Role(s)： Peer review

2017

Screening of academic papers

Role(s)： Peer review

2016

Screening of academic papers

Role(s)： Peer review

2015

西日本皮膚科（編集部員）

2013.4 - 2016.7

皮膚疾患画像ナショナルデータベースの拡充とAI活用診療支援システムの開発

2018.8

皮膚疾患ナショナルデータベースの構築のための画像収集とその解析（分担）

2018 - 2020

日本学術振興会  科学研究費助成事業  基盤研究(C)

皮膚悪性腫瘍の上皮間葉転換における新規転写因子OVOL1、OVOL2の機能解明（代表）

2018 - 2019

日本皮膚科学会 基礎医学研究費（資生堂寄付）

毛包に発現する新規転写因子OVOL1, OVOL2の機能解明（代表）

2018 - 2019

GSKジャパン研究助成

皮膚有棘細胞癌の上皮間葉転換における新規転写因子OVOLの機能解明（代表）

2018 - 2019

福岡県すこやか健康事業団 がん研究助成

悪性黒色腫におけるFOXM1の発現と治療ターゲットとしての可能性（代表）

2016 - 2017

日本学術振興会  科学研究費助成事業  基盤研究(C)

臨床医学論Ⅱ（皮膚）

2018.4 - 2018.9   First semester